Perception vs Perspective: Rethinking AI Adoption in Biopharma
AWS's Navdeep Singh on the gap between how AI is perceived and how it performs, and why adoption breaks on operations, not tech.
- Guest:
- Navdeep Singh, AWS Customer Success Leader
- Host:
- Jane Urban, Chief Data & Analytics Officer, Improzo
- Date:
- March 26, 2026
- Duration:
- 26 minutes
About the episode
In this episode, we explore the gap between how AI is perceived and how it is actually adopted in biopharma. While AI continues to generate excitement across the industry, real-world implementation often reveals challenges around execution, governance, and trust.
Host Jane Urban, CDAO at Improzo, sits down with Navdeep Singh, Customer Success Leader at AWS, to break down what it truly takes to move past pilots and build scalable, execution-focused AI adoption across commercial and medical workflows.
Final takeaway: AI adoption in biopharma isn’t just about capability, it’s about perspective. Organizations that focus on embedding AI into real workflows, with clarity, governance, and human oversight, will be the ones that turn potential into measurable impact.
Highlights from the episode
Summarize with AI
Three key points, generated from this article
Summarize with AI
Three key points, generated from this article
- AI adoption challenges are often operational, not technical.
- The gap between perception and reality is widening.
- Context is critical for decision-making.
- Governance builds trust in AI systems.
- Moving beyond pilots requires execution focus.
- Human judgment remains central.
- Adoption is a journey, not a switch.
- AI works best when it fits into existing systems.
- Real impact comes from clarity, not complexity.
Ask Improzo iZO®
What does this mean for your team?
Meet Our Expert
Jane Urban
Chief Data & Analytics Officer
Jane brings 20 years of life sciences experience as a practitioner and consultant, including VP roles at Otsuka and Takeda. She builds new functions and high-performing teams across commercial, medical and data.
